Cargando…
Antitumour reactions of monoclonal antibody against a human osteogenic-sarcoma cell line.
Monoclonal antibody against an osteogenic-sarcoma cell line (791T) was prepared by production and cloning of a somatic-cell hybrid between the mouse myeloma P3-NS1 and spleen cells from 791T-immunized mice. Three clones of hybridoma producing antibody against 791T, as detected by 125I-labelled Prote...
Autores principales: | Embleton, M. J., Gunn, B., Byers, V. S., Baldwin, R. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1981
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010673/ https://www.ncbi.nlm.nih.gov/pubmed/6941806 |
Ejemplares similares
-
Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
por: Embleton, M. J., et al.
Publicado: (1984) -
Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
por: Price, M. R., et al.
Publicado: (1982) -
Antitumour antibodies induced by rat embryo cells and spontaneous mammary carcinoma cells treated with 3-methylcholanthrene.
por: Reeve, J. G., et al.
Publicado: (1981) -
Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
por: Affleck, K., et al.
Publicado: (1992) -
Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugate.
por: Embleton, M. J., et al.
Publicado: (1983)